swg_trd, the pro-active market (that doesn't really exist today in the extend that PPHM's Exosome test makes it possible) with its SIMPLE binary outcome CANCR/NO CANCER is what will constitute the BULK of that 100-200BIL$
.
EXACTLY
so I re-defined yours under my 0.1 EXOSOME
"However, conceptionally we did not specify that this Exosome breakthrough creates a brand-new (in-GP office) consumer market that in dollars may far exceed the traditional in- hospital /oncologist /radiology lab $20billion (?) diagnostics, which sure as death and taxes you cannot pump to $200billion – that has been my point of contention."
it all depends on who bills
and reality check, there is not and never will be a trillion dollar cancer treatment market, worldwide, ever.
